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Abstract
Effective blood glucose control is essential for patients with diabetes. However, individual patients may not be able to monitor their blood
glucose level regularly because of all manner of real-life interference. In this paper, we propose a personalized diabetes prediction mechanism that
leverages smartphone-collected patient data and population data to drive personalized prediction. Unlike existing predictive models, this model
utilizes pooled population data and captures patient similarities, and eventually produces a personalized blood glucose prediction for an individual.
We have implemented the proposed model as a mobile application and have performed extensive experiments to evaluate its performance. The
experimental results demonstrate that the proposed prediction mechanism can improve the prediction accuracy and remedy the problem of sparse
data in the existing approaches.
c⃝ 2016 The Korean Institute of Communications Information Sciences. Publishing Services by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Diabetes is becoming increasingly common around the
world. In order to control blood sugar levels and prevent hy-
poglycemia, frequent blood glucose (BG) monitoring is needed
by diabetes patients and their healthcare professionals. Diabetes
control is aided by BG self-monitoring by facilitating the cre-
ation of an individualized BG profile. This profile can help
healthcare professionals to draw up an individualized treatment
plan for a particular patient. Moreover, it can also give dia-
betes patients and their families the ability to make appropriate
day-to-day treatment choices about diet and physical activity,
as well as about insulin or other agents [1].
However, frequent and regular monitoring of BG level is
difficult and often impractical in a patient’s daily life. The
frequency with which diabetic patients should monitor their
BG level varies from patient to patient. Most experts agree that
insulin-treated patients should monitor BG at least four times a
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bed. In some circumstances, however, patients are unable to
maintain this frequent monitoring; for example, a patient may
be in a meeting, may not have the testing devices with them, or
may forget the test. For this reason, accurate prediction of BG
level is very important for diabetes self-management.
There has been much research into automatic BG predic-
tion using machine learning algorithms. For example, in the
Artificial Pancreas Project [2], BG level is predicted so that
the insulin flow can be continuously adjusted to meet patient
needs. Despite the existing research, a challenge remains to
predict BG level accurately and make personalized recommen-
dations. Existing prediction models can be classified as either
population-based prediction (e.g., [3–6]) or patient-based pre-
diction (e.g., [7–10]). A population-based prediction of one pa-
tient’s situation is based on independent population data. As
shown in our experiments, the accuracy of this model in esti-
mating individual risk is relatively low. Patient-based predic-
tion normally requires a large amount of historical patient data
to make a usable prediction. Sometimes, this requirement can-
not be satisfied (e.g., for a new patient).
To address the aforementioned problems of existing
approaches, our work shifts from using either population-
or patient-based analysis and prediction to a synthesized
population/patient-based analysis and prediction. We propose a
personalized data-centric predictive model to predict patients’
es. Publishing Services by Elsevier B.V. This is an open access article under the
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collected from their smartphones, their historical information
kept in their smartphones, as well as the historical population
data. We leverage population data to drive personalized
prediction. In particular, we propose a three-stage evolution
model that includes a time-series regression model based on
personal history, a pooled panel data (PPD) regression model,
and a pre-clustered personalized regression model. A prediction
system can choose an appropriate model from the three
aforementioned models based on its data used for prediction.
2. Related work
There have been numerous studies of risk prediction
related to diabetes management. In 1996, Shanker proposed
the use of artificial neural networks to predict the onset of
diabetes mellitus among the Pima Indian female population
near Phoenix, Arizona [11]. Researchers have developed risk
scores and predictive models for diabetes screening based on
population studies [12]. More recently, Choi et al. developed
two models to screen for prediabetes using an artificial neural
network and support vector machine (SVM), and performed
a systematic evaluation of the models using internal and
external validation [13]. Zecchin et al. quantified the potential
benefits of glucose prediction in terms of a reduction in
the frequency/duration of hypoglycemia [14]. The Diabetes
Support System (4DSS) designed by Ohio University tries to
provide intelligent decision support systems for patients with
type 1 diabetes (T1D) who are on insulin pump therapy [15].
Different machine learning algorithms have been proposed
to predict BG level. Sandham et al. proposed the use of an
artificial neural network and neuro-fuzzy systems to predict
BG level for expert management of diabetes mellitus [8]. El-
Jabali [16] used artificial neural networks to create a dynamic
simulation model of T1D. Plis et al. [9] proposed a generic
physiological model of BG dynamics to generate informative
features for a support vector regression model to predict BG
levels. Based on their experiments, this model outperforms
diabetes experts at predicting BG levels, but its precision is still
relatively low at about 42%. Decision trees (DTs) have been
used for analysis and prediction in diabetes management [3,4].
For example, Pociot et al. proposed a novel DT-based analytical
method to predict T1D mellitus [3]. Han et al. used DTs to
build a model for diabetes prediction from the Pima Indians
Diabetes dataset [4]. Sudharsan et al. applied random forest
(RF), SVM, k-nearest neighbors, and naı¨ve Bayes to predict
hypoglycemia [5].
Based on the source of the training data, the aforementioned
prediction models can be classified as either population-
based (e.g., [3–6]) or patient-based (e.g., [7–10]). As already
mentioned, they suffer from issues of low accuracy and/or
sparse data.
3. Methodology
3.1. Data collection
Owing to the near-ubiquitous use of smartphones, we
can use them to collect patient information such as BGmeasurements taken at regular intervals, and the corresponding
daily events that impact the BG levels such as insulin,
meals, exercise, and sleep. The ambient sensing features of
a smartphone can help us collect some user information
(e.g., exercise and sleep) automatically. Some other data
(e.g., insulin dose) need to be entered manually. Because
of its popularity, we mainly use touch-based gestures as the
default input method. The collected data are preprocessed and
automatically uploaded to the cloud.
3.2. Personalized prediction
We apply a three-stage evolution model to make more
accurate and personalized BG predictions.
(1) Time-series prediction model based on patient data
Because smartphone-collected BG measurements have a
natural temporal ordering, we can model the problem of
predicting BG level as one of forecasting a time series. A
time series is a sequence of data points, typically consisting of
successive measurements made over a time interval. A time-
series dataset differs from a regular one in that there is a natural
ordering to the observations in the former. We confine our study
to discrete time series. Our BG prediction problem is to use BG
measurements up to time t to predict a future BG level at time
t + 1. This BG prediction problem can be modeled as follows:
BGt+1 = f (BGt ,BGt−1,BGt−2, . . . ,BGt−n). (1)
For an observed BG series with n points, where t refers
to the most recent observation and t − n is the most distant
observation, a future BG value at t + 1 can be estimated with
a function f . Function f is known as the model, and is used to
obtain an estimated value BGt+1.
(2) Pooled-panel-data regression model
The aforementioned time-series regression model makes
predictions based on an individual patient’s historical data.
If the system has a large amount of historical data for the
individual, this model can make better predictions. However, an
individual patient may have very limited historical data. In the
extreme case, the individual might not have any previous data at
all. We understand that the inability to predict with time-series
regression models is a small-sample issue. To address this issue,
we propose to employ panel data to increase the sample size. A
pooled panel data (PPD) regression model takes into account
the fact that historical information of all patients enables cross-
patient information sharing and thus overcomes issues related
to data sparsity.
We choose linear regression to realize our PPD regression
model for predicting BG level. Linear regression can model
the relationship between the scalar dependent variable BG and
the explanatory (or independent) variables. Let BG denote the
dependent variable whose values we wish to predict, and let
X1, . . . , Xk denote the independent variables from which it is
to be predicted; the value of variable X i in period t (or in row t
of the dataset) is denoted by X i t . For example, in our dataset, X i
could be insulin dose, hypoglycemic symptoms, meal ingestion,
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or exercise activity. The equation for computing the predicted
value of BGt is
BGt = b0 + b1X1t + b2X2t + · · · + bkXkt . (2)
(3) Pre-clustered personalized regression model
The predictive performance of the PPD model may be
influenced by the significant underlying model heterogeneity
due to the variety of patients. To address this issue and improve
the precision, we segment patients into groups whose prediction
models are quite similar. In other words, we cluster patient
data in order to group similar patients. The goal of clustering
is to remove the influence of patients who have little or
no similarity with the testing patient for whom predictions
are being made. Clustering is based on similarities between
patients, so that patients who are quite different from the testing
patient are removed from his/her cluster. Patients in other
clusters do not contribute to the prediction score of the testing
patient. Thus, removing these patients does not result in loss of
information, but effectively reduces the noise caused by these
data. Clustering provides an additional benefit by reducing the
number of data used for prediction, which both simplifies and
improves the prediction results. In order to measure similarity
between patients, an appropriate similarity measurement should
be applied. The chosen measurement should correspond to
the characteristics that distinguish the clusters embedded in
the data. Candidate similarity measurement includes Euclidean
distance, cosine similarity, Jaccard similarity, and Pearson
similarity.
4. Implementation and evaluation
We have implemented the proposed model and integrated
it into our prototype mobile application MobiDiaBTs [17].
Fig. 1 shows screenshots of the mobile application running on
an iPhone 6 Plus. As shown, the mobile application provides
various self-management functions to users. The “Overview”
option gives users a summarized view of their historical health
data. The “Glucose”, “Medications”, “Activity”, “Diet”, and
“BP” options provide users with a friendly interface with
which to input (or automatically collect) their health-related
data. Among these functions, the “Warnings” component calls
the proposed BG prediction model and automatically sends
warning messages to users based on the predicted BG level.Table 1
Comparison of different time-series regression approaches.
Metric SVM DT RF
RMSE 68.76 41.06 39.73
MAE 63.097 36.423 37.586
R2 0.05769283 0.29638461 0.79896364
We also performed experiments to evaluate the performance
of the proposed model using the diabetes dataset from the
UCI Machine Learning Repository [18]. This dataset includes
70 sets of data recorded on diabetes patients. Among the
many criteria for comparing forecasting models, we choose
the three most commonly used ones, namely mean absolute
error (MAE), root-mean-square error (RMSE), and coefficient
of determination (R2) to evaluate the prediction performance.
The MAE is the average error between the predicted BG level
and the actual BG level:
MAE = 1
n
n
i=1
|pi − yi |. (3)
Here, p is the predicted BG level, y is the actual BG level, and
n is the number of BG measurements taken.
The RMSE measures the standard deviation of the
differences in the predicted BG level (yˆ) and the actual BG
level (y):
RMSE =
 ni=1(yi − yˆi )2
n
. (4)
The coefficient of determination, denoted as R2, measures
the proportion of the variance of the BG level, which is the
dependent variable that can be predicted from the given features
(i.e., the independent variables). This is an indicator that shows
how well the data fit to the model:
R2 = 1− Sum of squares of the residual
Explained sum of squares
. (5)
The explained sum of squares is the sum of the squares of the
differences of the predicted values and the mean value of the
response variable y, the BG level.
The first set of experiments was carried out to analyze
the performance of the patient-based regression model. Fig. 2
compares the prediction performance of three different time-
series regression approaches, namely the SVM-based approach,
the DT-based approach, and the RF-based approach. As
illustrated, the accuracy of the SVM-based approach is not
ideal. The RF model has the best prediction performance among
the three.
Table 1 also lists the comparison of the three approaches
using three different error metrics. We can see that both of
the DT and RF models perform better than the SVM model in
relation to RMSE, MAE, and R2.
In the second part of the experiment, we studied the impact
of sample data size (i.e., frequency of BG measurement) on
prediction accuracy. We then verified the performance of the
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Comparison of pooled panel data (PPD)-based prediction with pre-cluster-based predictions.
Metric Panel 2-cluster 3-cluster 5-cluster 9-cluster 43-cluster
RMSE 39.438 36.695 33.573 33.074 31.193 27.453
R2 0.7681 0.8047 0.8014 0.8032 0.8156 0.8883Fig. 2. Predicted blood glucose (BG) levels using support vector machine
(SVM), decision tree (DT), and random forest (RF) methods.
Fig. 3. Predicted BG levels using PPD regression and different-sized personal
data (I0: patient-based prediction using all the samples in the dataset, I1:
patient-based prediction with half the sample size. I2: patient-based prediction
with a quarter of the sample size).
PPD regression model in remedying the data sparsity problem
of the patient-based regression mode. Fig. 3 illustrates the
predictive performance under different-sized patient data. In
the figure, I0 represents patient-based prediction using all the
samples in the dataset, I1 represents patient-based prediction
with half the sample size, and I2 represents patient-based
prediction with a quarter of the sample size. We reduced
the sample size by reducing the BG measurement frequency.
As shown in Fig. 3, as the frequency of an individual’s BG
measurements is reduced, the prediction accuracy decreases.
Prediction using I2 (a quarter of the sample) deviated from the
actual value, making it a useless prediction. Fig. 3 compares
the performance of the regression model using PPD and the
regression model using different-sized patient data. We can see
that PPD can effectively remedy the small-sample-size problem
by using the historical information of all the other patients to
allow for cross-patient information sharing. This experiment
tells us that, in the case of sparse personal data, we can turn
to PPD as a solution.In the third part of the experiment, we aimed to verify
that pre-clustered regression would improve the prediction
accuracy by providing more personalized prediction. Of course,
like PPD-based prediction, this approach would also help
to remedy the data sparsity problem associated with patient
data. We use hierarchical clustering to group patients based
on their similarity. Because of the limitation of the dataset,
we can only measure the similarity based on feature patterns
specified in the dataset. Table 2 compares the PPD-based
prediction performance with that of personalized pre-cluster-
based prediction with different cluster sizes. As can be seen
from the table, the latter type of prediction is more accurate. The
cluster-based prediction captures patient characteristics and can
therefore make more personalized predictions. Table 2 also
shows that the error rate continues to decrease when we refine
the clusters. However, because of the small dataset with only 70
patients, the improvement due to clustering is not significant.
From these experiments, we can see that the proposed pre-
cluster-based prediction can improve the predictive accuracy
compared to that of PPD-based prediction (e.g., [3–6]). It can
also remedy the data sparsity problem suffered by approaches
that are based on the data of individual patients (e.g., [7–10]).
5. Conclusions
The global diabetes epidemic is a serious public health
challenge. Close BG monitoring is important for diabetes self-
management. However, patients are not necessarily able to
measure their BG levels regularly. The goal of this study was
to develop a personalized BG prediction model to predict
patient BG levels accurately and automatically. Our work
moves away from population or patient-based analysis and
prediction to a synthesis of population and patient-based
analysis and prediction. The proposed prediction models have
been evaluated by extensive simulation experiments. The
experimental results demonstrate that the proposed model
improves the prediction accuracy and remedies the data sparsity
problem of the existing models.
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